CSL (ASX:CSL) earnings release. How does it compare to expectations?

Here’s how the CSL result compares to what the market was expecting…

| More on:
man looks at phone while disappointed

Image source: Getty Images

The CSL Limited (ASX: CSL) share price is trading lower on Wednesday following the release of its full year results.

In afternoon trade, the biotherapeutics company’s shares are down 1% to $295.35.

How did CSL perform in FY 2021?

For the 12 months ended 30 June, CSL reported a 9.6% in constant currency revenue to US$10,026 million.

This was driven by a 6% increase in CSL Behring revenue and a 30% increase in revenue from its influenza vaccines business, Seqirus. This reflects strong demand for its immunoglobulin portfolio and record demand for seasonal influenza vaccines.

On the bottom line, CSL reported net profit after tax growth of 10% to US$2,307 million. This compares favourably to its guidance of 3% to 8% growth in FY 2021.

However, that wasn’t enough to keep the CSL share price from dropping today. Investors have been selling its shares after management warned that its FY 2022 profits would decline by 2.5% to 6.8% on its constant currency result or 5% to 9% on its reported result.

How does this compare to expectations?

Analysts at Goldman Sachs have been looking over the result and have given their feedback.

The broker said: “FY21 modestly ahead of expectations (revenue/EBIT/NPAT +2%/-1%/+2% vs. VA consensus). CSL delivered +10% revenue and +10% earnings growth in a year of widely understood challenges. In the core Behring division, revenues grew +6% (vs. cons +5%), with the entirety of the beat driven by IG.”

“Seqirus held up reasonably well after a stellar 1H, although ultimately missed consensus EBIT expectations by -7% despite a modest +1% beat on sales,” it added.

As mentioned above, the main drag on the CSL share price appears to be its guidance. Goldman Sachs notes that constant currency net profit after tax of US$2,150 million to US$2,250 million falls short of the analyst consensus estimate of US$2,289 million by 6% to 2%.

And while it acknowledges that management is often conservative with its guidance, these are unprecedented times.

Goldman said: “FY22 net profit is guided to $2,150m-2,250m (vs. FY21 level of $2,375m) on sales guidance of +2-5% (both in constant currency). CSL has stated that FY22 will be a ‘transitional year’ and, despite ‘robust demand’, guides to further margin pressure, primarily due to increased plasma costs. Whilst management has a long-standing reputation for conservative guidance, the current conditions are clearly unprecedented.”

Should you invest $1,000 in CSL right now?

Before you consider CSL, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and CSL wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Top 10 blank list on chalkboard
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

a man with a wry smile is behind ascending piles of coins as he places another coin on top of the tallest stack.
Share Market News

Can ASX 200 banks really see a 15% profit jump if the cash rate hits 1%?

These analysts are predicting big returns for banks in the rising interest rate environment.

Read more »

An office worker and his desk covered in yellow post-it notes
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Wednesday

We take a look at the most traded ASX 200 shares by volume today.

Read more »

an oil refinery worker checks her laptop computer in front of a backdrop of oil refinery infrastructure. The woman has a serious look on her face.
Energy Shares

ASX 200 energy shares in focus amid frightening global supply crisis

A dearth of new fossil fuel projects in recent years has opened the door to today's global energy crisis.

Read more »

A happy man and woman sit having a coffee in a cafe while she holds up her phone to show him the ASX shares that did best today
Share Market News

ASX 200 midday update: BlueScope and Fortescue rise, Boral tumbles

The ASX 200 is having a strong day on Wednesday...

Read more »

A man standing in a red rock mine is covered by a sheet of gold blowing in the wind.

What’s sending the Northern Star share price higher today?

The gold miner reported it will return 20% to 30% of cash earnings as dividend payouts at its investor presentation,…

Read more »

Legendary share market investing expert and owner of Berkshire Hathaway Warren Buffett
Share Market News

Warren Buffett’s been bargain hunting following the stock market sell-off. Here’s the sector he’s been buying (and selling)

We check the investing guru's recent buys and sells.

Read more »

Share Market News

5 things to watch on the ASX 200 on Wednesday

A strong day is expected on the ASX 200 on Wednesday...

Read more »